ãããã¤ã³ã¹ãã¼ã«ä»£è¡¨ã®ã©ã¤ãããã¯ããã°
ä¼å¢æµ·è太éããã° ä¸çã®ã¤ã³ããªã¢ã¨é貨ã¨ææ¿å ·ãApple(iPhone)ãé£ããã¡ãã·ã§ã³ãã¢ã¼ãããã¶ã¤ã³ãéå¦ã³ãã¿ãåèã¨æ±äº¬ã®é£ã¹æ©ããªã©ãã¾ã¨ããããã°ã§ãã ã©ããããããããããã³é貨ã大好ããªä¼å¢æµ·è太é(@iseebitaroublog)ã§ãããããã§ããããããã°ã«ãããè¦ã¤ããã®ã§ç´¹ä»ãã¾ããã©ããæããããã¶ã¤ã³ã§ããããé湯ã®å£ã«æããã¦ããå¯å£«å±±ã§ãããããçµµã§å¯å£«å±±ã®æ¯è²ãæããããã°ã«ããã§ãã ã¢ããç»åã§ããæããããããªã«ã©ã¼ã®ãããçµµã§ãããã®ãã°ã«ããã§é£²ãã ãæ°åãæ´ãæ´ããããã§ããã¡ããã¨å¹å¸ãããããã§ãã触ãå¿å°ãé湯ã®å£ç»ã®ã¿ã¤ã«ã§ã(ç¬)ã èé¢ã§ããèé¢ã¯æ®éã§ã(ç¬)ã 大ã¨å°ãããã¾ãã ãã¡ãã¯å°ã3ã¤ä¸¦ã¹ãç»åã§ãã 3ã¤è³¼å ¥ãã¦ããããã³æ£ã«ä¸¦ã¹ã¦é£¾ãããã§ããããããã³æ£ã®ä¸ãé湯ã®å£ã«ãªãã¾ãããããããã§ã(ç¬
æ ¶æ義塾大å¦(æ ¶å¿å¤§)ã¯5æ8æ¥ãæ å ±é示è«æ±ã«ããæä¾ãåããå ¨å½å¦åã»å¦ç¿ç¶æ³èª¿æ»(å ¨å½å¦ã)ã¨æ¨ªæµå¸å¦ç¿ç¶æ³èª¿æ»ã®å¦æ ¡å¥å¹³åç¹ãã¼ã¿ãå©ç¨ãã¦ãå¦ç´è¦æ¨¡ã®ç¸®å°ãå¦åã®ä¼¸ã³ã«ä¸ããå½±é¿ãåæããå°å¦6å¹´çã»ä¸å¦3å¹´çã®å½èªã¨ç®æ°/æ°å¦ã®ä¸ã§ã¯ãå°å¦æ ¡ã®å½èªãé¤ããå¦ç´è¦æ¨¡ç¸®å°ã®å¹æã確èªãããã¨ã¯ã§ããªãã£ãã¨çºè¡¨ããã ææã¯ãæ ¶æ大 çµæ¸å¦é¨ã®èµ¤æè±å¤«ææ(æè²çµæ¸å¦)ã¨ãæ¥æ¬å¦è¡æ¯èä¼ç¹å¥ç 究å¡(PD)ã®ä¸æ亮ä»(2013å¹´3æã¾ã§æ ¶æ義塾大å¦å¤§å¦é¢çµæ¸å¦ç 究ç§å士課ç¨)ãã®ç 究ãã¼ã ã«ãããã®ãç 究ã®è©³ç´°ãªå 容ã¯ãçµæ¸å¦å°éèªãJapanese Economic Reviewãã«æ²è¼ãããäºå®ã ã çµæ¸ååéçºæ©æ§(OECD)ã®èª¿æ»ã«ããã°ã2010å¹´ã®æ¥æ¬ã®å°å¦æ ¡ã«ããã1å¦ç´å½ããã®çå¾æ°(å¦ç´è¦æ¨¡)ã®å¹³åã¯28.0人ã§ãOECD諸å½ã®å¹³åå¦ç´è¦æ¨¡21.2人ã¨æ¯ã¹ã¦å¤§ãããª
2013-05-10 ä»é±ã®Scienceã®è¡¨ç´ããã°ã¶ã ã¿ããã ã¨è©±é¡ã«ï¼HIVã¯ã¯ãã³éçºã«ãã¬ã¼ã¯ã¹ã«ã¼ï¼ ä»é±ã®ãµã¤ã¨ã³ã¹ã®è¡¨ç´ãè¦ã¦ãã°ã¶ã ãæãåºãã®ã¯ã¯ã·ã ããâ ãã®ãããããã¡ãã (@shinopp) 2013å¹´5æ10æ¥ http://www.sciencemag.org/content/340/6133.cover-expansion 確ãã«ã ä¸å¿èª¬æãã¨ãã¾ãã¨ï¼ã¨ãããCover Photo â 10 May 2013, 340 (6133)åç §ã§ããï¼ãHIVã¯ã¯ãã³éçºã®ç 究ã§ããHIVæåã®å¡ï¼ãã°ã¶ã æ¬ä½ï¼ã¨Bç´°èåé§ä½ã«ãã£ã¤ãé¨åï¼è¶³ï¼ããã§ãã¦ãããããã§Bç´°èã«HIVä¸åæä½ãä½ããããã¨ããã¹ã³ãã¼ã è«æ Rational HIV Immunogen Design to Target Specific Germline B Cell
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}